Stomach and Colorectal Cancer Screening
Our Services
Stomach and Colorectal Cancer Screening: Early Detection Saves Lives
Screening for stomach and colorectal cancer is crucial for early detection and prevention of these potentially life-threatening diseases. Both types of cancer often develop slowly and may not show symptoms until they are at an advanced stage, making regular screening an essential tool in identifying cancer early, when it is most treatable.
Understanding the importance of these screenings, who should be screened, and the available methods can significantly improve outcomes and save lives.
Why is Cancer Screening Important?
Stomach and colorectal cancers are among the most common cancers worldwide. Early detection through screening can:
- Identify Precancerous Conditions: Colorectal cancer almost always develops from precancerous polyps in the colon or rectum, whereas most stomach cancer develops from precancerous conditions such as thinning of the stomach lining (atrophic gastritis), changes in the stomach tissue (intestinal metaplasia), and abnormal cell growth (dysplasia). Screening can detect abnormal changes or polyps in the stomach or colon that could develop into cancer if left untreated. Removing these polyps or monitoring changes can prevent cancer from developing.
- Detect Cancer Early: When cancer is found at an early stage, treatment is more likely to be successful, leading to better outcomes and survival rates.
- Reduce Mortality: Regular screening has been shown to reduce the mortality rates of colorectal cancer significantly. Screening for stomach cancer remains controversial, even in regions with a relatively high incidence. However, it may facilitate the early detection of cancer and contribute to a reduction in overall stomach cancer mortality.
Who Should Be Screened?
The guidelines for stomach and colorectal cancer screening vary depending on individual risk factors, such as age, family history, and overall health:
Colorectal Cancer Screening
- Average-Risk Individuals: All individuals without a personal history of colorectal cancer or advanced, high-risk polyps, inflammatory bowel disease (IBD), known genetic syndromes that can cause colorectal cancer, or a family history of colorectal cancer or advanced, high-risk polyps are considered at average risk for colorectal cancer. Regular screening is recommended for everyone aged 45 and older. The age was recently lowered from 50 to 45 due to rising rates of colorectal cancer in younger adults..
- High-Risk Individuals: Those with a family history of colorectal cancer or advanced, high-risk polyps, a personal history of colorectal cancer or advanced, high-risk polyps, IBD, or known genetic syndromes that can cause colorectal cancer should start screening earlier and may need to be screened more frequently. .
Stomach Cancer Screening
- Screening for stomach cancer is controversial and not routinely recommended for the general population in many countries. Some countries with a high incidence of stomach cancer (eg, Japan, Korea) have introduced population-wide screening for stomach cancer. The recommended screening modality and screening intervals vary.
- Individuals at high risk – such as those with a family history of stomach cancer, certain genetic conditions (like hereditary diffuse gastric cancer), or gastric intestinal metaplasia—may benefit from regular screening.
Screening Methods for Colorectal Cancer
Several screening methods are available for colorectal cancer. The choice of method depends on individual risk factors, preferences, and the availability of tests:
- Colonoscopy:
- What It is: A colonoscopy is the most comprehensive screening method, allowing doctors to examine the entire colon and rectum. During the procedure, a flexible tube with a camera (colonoscope) is inserted into the rectum to detect polyps or cancer. Polyps can be removed during the procedure.
- Frequency: Every 10 years for average-risk individuals if no polyps are found. More frequent screening may be needed if polyps are found or if the individual is at higher risk.
- Fecal Immunochemical Test (FIT):
- What It is: The FIT test checks for hidden blood in the stool, which can be a sign of polyps or colorectal cancer. It is a non-invasive, at-home test.
- Frequency: Annually for average-risk individuals. A positive FIT must be followed up with a colonoscopy to look for cancer.
- Stool DNA Test (Cologuard):
- What It is: This test detects both blood and abnormal DNA in stool that may indicate cancer or precancerous polyps.
- Frequency: Every 3 years for average-risk individuals.
- Flexible Sigmoidoscopy:
- What It is: Similar to a colonoscopy, but only examines the lower part of the colon. If polyps or abnormalities are found, a full colonoscopy may be required.
- Frequency: Every 5 years, or every 10 years when combined with annual FIT.
- CT Colonography (Virtual Colonoscopy):
- What It Is: A CT scan creates detailed images of the colon and rectum. If polyps or other abnormalities are detected, a traditional colonoscopy is needed for further evaluation.
- Frequency: Every 5 years for average-risk individuals.
Screening Methods for Stomach Cancer
Screening methods for stomach cancer are less standardized but may include:
- Upper Endoscopy (EGD):
- What It is: An upper endoscopy involves inserting a flexible tube with a camera (endoscope) through the mouth to examine the stomach lining. Biopsies can be taken during the procedure if suspicious areas are found.
- When It’s Used: Recommended for individuals at high risk for stomach cancer, particularly if symptoms or abnormal findings are present.
- Barium Swallow X-Ray:
- What It is: This imaging test involves swallowing a barium solution, which coats the stomach lining, making it visible on X-rays. It can help detect abnormalities in the stomach but is less commonly used than endoscopy.
- When It’s Used: Used in cases where an upper endoscopy is not feasible, though it is less effective for detecting early-stage stomach cancer.
- Helicobacter Pylori Testing*:
- What It is: Testing for H. pylori infection, a major risk factor for stomach cancer, is recommended in certain high-risk populations. If detected, treatment can reduce the risk of developing stomach cancer.
- When It’s Used: Recommended for individuals with a history of ulcers, chronic gastritis, or those living in areas with high rates of stomach cancer.
What Happens After Screening?
If screening detects polyps, abnormal tissue, or cancer, the next steps may include:
- Polyp Removal: Polyps found during a colonoscopy can often be removed immediately, preventing them from becoming cancerous.
- Biopsy: Suspicious areas identified during endoscopy or colonoscopy may be biopsied for further analysis to determine if cancer or precancerous conditions are present.
- Follow-Up Testing: Depending on the results, more frequent screenings or additional tests may be needed to monitor the situation or guide treatment.
- Treatment: If cancer is detected, your healthcare provider will discuss treatment options, which may include surgery, chemotherapy, radiation, or targeted therapies.
Conclusion
Screening for stomach and colorectal cancer is a powerful tool in the fight against cancer. Regular screening can detect cancer early, when treatment is most effective, or prevent it altogether by identifying and removing precancerous polyps.
If you are at risk for stomach or colorectal cancer, it’s important to talk to your healthcare provider about the appropriate screening methods and schedule for you. Early detection through regular screening can save lives and improve outcomes, making it an essential part of maintaining your health.
Get in Touch With Our Doctors
Fill out the form below, and our team will promptly assist you with your needs.